Bayer HealthCare / Press

FDA Approves Bayer’s Finacea® (azelaic acid) Foam for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.
    more

  • TV Footage

    In this section you can find videos for editorial coverage. » more

    Videos

    The video section provides an overview of interesting videos for viewing. » more

Bayer HealthCare Links

RSS Feed
RSS Feed

http://press.healthcare.bayer.com/en/press/index.php

Copyright © Bayer HealthCare AG